β-Blockers in the Post–Myocardial Infarction Patient
Key result
Long-term beta-blocker use falls below ~50% in post-MI patients due to physician concerns.
Why the study?
Should long-term beta-blockers be recommended for post-myocardial infarction patients?
Population
Post-myocardial infarction patients
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Identifies a major gap in post-MI beta-blocker prescribing; leaves open whether indefinite guidelines require contemporary reevaluation.
Structured PICO
Should long-term beta-blockers be recommended for post-myocardial infarction patients?
P
Population
Post-myocardial infarction patients (illustrated by two cases: a 76-year-old man with anterior STEMI and LVEF 35%, and a 67-year-old woman with NSTEMI and LVEF 50%)
I
Intervention
Long-term beta-blocker therapy
O
Outcome
Secondary prevention of MI and death
Despite strong guideline recommendations for long-term beta-blocker therapy post-MI, physician reluctance leads to significant underprescription in the chronic setting.
Cite This Study
Gheorghiade et al. (2002) conducted a review in Myocardial Infarction. Beta-blockers was evaluated. Despite guideline recommendations for indefinite use, less than half of post-myocardial infarction patients are prescribed long-term beta-blockers due to physician concerns.